Positive Preclinical Results for Lung Cancer Drug Announced at Annual Meeting of Cancer Research
News
ARIAD Pharmaceuticals, a pharmaceutical company dedicated to discovering innovative medicines for the improvement of cancer patients, recently presented preclinical study results of its investigational drug AP32788, a tyrosine kinase inhibitor (TKI) targeting ... Read more